Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients

Anthracyclines remain a cornerstone of cancer therapy but are associated with a significant risk of cardiotoxicity, which can lead to overt heart failure. The risk is modulated by cumulative dose, pre-existing cardiovascular disease, and patient-specific factors. As cancer survival improves, the lon...

Full description

Bibliographic Details

Published in:	Journal of Cardiovascular Development and Disease
Main Authors:	Luigi Spadafora, Francesca Maria Di Muro, Chiara Intonti, Ludovica Massa, Mauro Monelli, Roberto Franco Enrico Pedretti, Edvige Palazzo Adriano, Pasquale Guarini, Gaia Cantiello, Marco Bernardi, Federico Russo, Stefano Cacciatore, Pierre Sabouret, Michele Golino, Giuseppe Biondi Zoccai, Francesca Romana Zimatore, Laura Adelaide Dalla Vecchia
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Subjects:	anthracyclines anthracycline-induced cardiotoxicity prevention exercise pharmacological strategies cardio-oncology
Online Access:	https://www.mdpi.com/2308-3425/12/6/212